Three Indian manufacturing units in WEF's fourth industrial revolution champion list
The Indian production facility of Mondelez, Dr. Reddy’s, and Cipla have joined WEF's Global Lighthouse Network
cipla 2
October 2022
July 2022
May 2022
February 2022
January 2022
December 2021
October 2021
Sensex, Nifty to open higher; Cipla, RIL, HDFC Bank, Vedanta, Tata Steel, Marico shares in focus
The Sensex and Nifty are poised to open higher on Tuesday, following firm cues from Asian markets and positive trends on SGX Nifty.
Soft opening seen for Sensex, Nifty; Vodafone Idea, Adani Ports, Cipla, PNB, Wipro shares eyed
The Sensex and Nifty are poised to open on a soft note on Wednesday, tracking mixed cues from global peers as looming fear about aggressive rate hikes weighed on investors’ sentiments.
Why Cipla shares tumbled 5% today?
The pharma stock has generated a 10% return in the past year but has remained flat since the beginning of the calendar year 2022.
Sensex, Nifty to open in red on U.S. rate hike fears; BPCL, Axis bank, Cipla, PNB in focus
The BSE Sensex and the NSE Nifty are expected to open lower on Thursday as stocks tumbled on Wall Street and in Asia, while trends on SGX Nifty also indicated a gap-down opening for domestic bourses.
Sensex ends 477 pts higher, Nifty above 17,200; Asian Paints, Sun Pharma, M&M shine
All the sectoral indices ended in the green, while capital goods, auto IT, and PSU bank gained the most, led by Asian Paints, Sun Pharma, and M&M.
55 Indian pharma cos capable of mRNA vaccines
Almost every major Indian pharmaceutical company, including Cipla, Dr Reddy’s, Sun Pharma and Biocon, are on the list of companies which can produce mRNA Covid-19 vaccines
Sensex, Nifty to fall amid Omicron fears; Shriram Properties, Future Retail, Cipla in focus
The BSE Sensex and the NSE Nifty are expected to open lower today following weak global cues and rising concerns about Omicron variant of COVID-19.
Watch: Cipla on Covid and beyond
In the latest episode of Biz Buzz, Umang Vohra, global MD & CEO, Cipla, talks about the paradigm shift in the Indian pharma industry, and Cipla's plans for booster shots of Covid-19 vaccine.
